CRISPR-Cas for genome editing: Classification, mechanism, designing and applications

S Bhatia, SK Yadav - International Journal of Biological Macromolecules, 2023 - Elsevier
Clustered regularly interspersed short pallindromic repeats (CRISPR) and CRISPR
associated proteins (Cas) system (CRISPR-Cas) came into light as prokaryotic defence …

Recent trends and advancements in CRISPR-based tools for enhancing resistance against plant pathogens

M Ijaz, F Khan, HEM Zaki, MM Khan, KSA Radwan… - Plants, 2023 - mdpi.com
Targeted genome editing technologies are becoming the most important and widely used
genetic tools in studies of phytopathology. The “clustered regularly interspaced short …

Sensitive and amplification-free electrochemiluminescence biosensor for HPV-16 detection based on CRISPR/Cas12a and DNA tetrahedron nanostructures

L Yu, Y Peng, M Sheng, Q Wang, J Huang, X Yang - ACS sensors, 2023 - ACS Publications
Rapid and accurate detection of biomarkers was very important for early screening and
treatment of diseases. Herein, a sensitive and amplification-free electrochemiluminescence …

[HTML][HTML] Assessment of the safety and metabolism characteristics of Streptococcus thermophilus DMST-H2 based on complete genome and phenotype analysis

Y Xu, J Hu, D Liu, J Tang, M Liang, J Wu, J Xiong - LWT, 2023 - Elsevier
A genome-based systematic analysis combined with phenotypic experiments was
conducted to evaluate the safety properties and metabolic characteristics of Streptococcus …

Bacterial enzymes: powerful tools for protein labeling, cell signaling, and therapeutic discovery

L Liu, JL Gray, EW Tate, A Yang - Trends in Biotechnology, 2023 - cell.com
Bacteria have evolved a diverse set of enzymes that enable them to subvert host defense
mechanisms as well as to form part of the prokaryotic immune system. Due to their unique …

[HTML][HTML] Biomaterials-mediated CRISPR/Cas9 delivery: recent challenges and opportunities in gene therapy

AK Dubey, E Mostafavi - Frontiers in Chemistry, 2023 - ncbi.nlm.nih.gov
The use of biomaterials in delivering CRISPR/Cas9 for gene therapy in infectious diseases
holds tremendous potential. This innovative approach combines the advantages of …

CRISPR‐Cas9 technology: As an efficient genome modification tool in the cancer diagnosis and treatment

G Behrouzian Fard, MH Ahmadi… - Biotechnology and …, 2024 - Wiley Online Library
Cancer is the second most common cause of death globally and is a major public health
concern. Managing this disease is difficult due to its multiple stages and numerous genetic …

Targeting MHC-I inhibitory pathways for cancer immunotherapy

J Wang, Q Lu, X Chen, I Aifantis - Trends in Immunology, 2024 - cell.com
The MHC-I antigen presentation (AP) pathway is key to shaping mammalian CD8+ T cell
immunity, with its aberrant expression closely linked to low tumor immunogenicity and …

Exosomes for CRISPR-Cas9 Delivery: The Cutting Edge in Genome Editing

C Aslan, NM Zolbanin, F Faraji, R Jafari - Molecular Biotechnology, 2023 - Springer
Gene mutation correction was challenging until the discovery of clustered regularly
interspaced short palindromic repeats (CRISPR) and CRISPR-associated protein (Cas) …

CRISPR/Cas genome editing in triple negative breast cancer: Current situation and future directions

L Fu, Z Li, Y Ren, H Yu, B Liu, Y Qiu - Biochemical Pharmacology, 2023 - Elsevier
Triple negative breast cancer (TNBC) has been well-known to be closely associated with the
abnormal expression of both oncogenes and tumor suppressors. Although several …